OTCMKTS:RADLY Raia Drogasil 5/7/2025 Earnings Results & Report $4.16 +0.03 (+0.60%) As of 12:09 PM Eastern Raia Drogasil was expected to report earnings on May 7, 2025, before market opens. Analysts expected earnings of $0.0242 per share on revenue of $10.21 billion. Confirmed results have not been posted yet. This page will update with the reported figures, conference call transcript, and earnings documents as they become available. Research:ProfileEarnings HistoryForecast Earnings Announcement Details Announcement DateMay 7, 2025TimeBefore Market Opens Raia Drogasil EPS ResultsActual EPSN/AConsensus EPS $0.0242Beat/MissN/AOne Year Ago EPSN/ARaia Drogasil Revenue ResultsActual RevenueN/AExpected Revenue$10.21 billionBeat/MissN/AYoY Revenue GrowthN/AConference Call ResourcesEarnings HistoryCompany Profile Raia Drogasil Earnings FAQ When is Raia Drogasil's next earnings date? Raia Drogasil's next earnings date is estimated for Tuesday, November 3, 2026. MarketBeat tracks confirmed and estimated earnings dates for Raia Drogasil on the company's earnings history page. Raia Drogasil Earnings HeadlinesFinancial Review: Raia Drogasil (RADLY) vs. Its PeersOctober 8 at 5:44 AM | americanbankingnews.comRaia Drogasil (RADLY) and Its Peers Financial ComparisonOctober 8 at 4:59 AM | americanbankingnews.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 9 at 1:00 AM | Chaikin Analytics (Ad)Raia Drogasil (RADLY) and Its Competitors Critical ComparisonOctober 7 at 3:59 AM | americanbankingnews.comHead to Head Review: Raia Drogasil (OTCMKTS:RADLY) vs. Ingles Markets (NASDAQ:IMKTA)October 6 at 12:15 PM | americanbankingnews.comRaia Drogasil (OTCMKTS:RADLY) Shares Up 30% - Here's What HappenedOctober 5, 2026 | americanbankingnews.comSee More Raia Drogasil Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Raia Drogasil? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Raia Drogasil and other key companies, straight to your email. Email Address About Raia DrogasilRaia Drogasil (OTCMKTS:RADLY), known as RD Saúde, is a Brazilian healthcare and pharmacy retail company. It operates a nationwide network of drugstores under the Raia and Drogasil brands, offering prescription medicines, over-the-counter products, vitamins, personal-care items, cosmetics and other health-related merchandise. The company also provides digital shopping and delivery services through its online channels, supporting customers with prescription fulfillment and access to pharmacy products. Its stores and digital operations primarily serve consumers throughout Brazil, with a focus on combining retail pharmacy services with broader healthcare offerings. Raia Drogasil was created in 2011 through the merger of Drogasil and Droga Raia, two established Brazilian pharmacy chains. The company later adopted the RD Saúde name to reflect its broader healthcare strategy, while continuing to operate its established pharmacy brands.View Raia Drogasil ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep ValueMicrosoft Is Almost Back to $555—Now the Hard Part BeginsSkydance Just Became a Media Giant—With an $80 Billion Debt Load Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
